Across TCGA pan-cancer cohorts, GPR32P1 RNA differs between tumor and matched normal tissue in 1 of 18 cancer types tested, making tumor–normal expression one of GPR32P1’s most consistent transcriptional readouts.
The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where GPR32P1 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types GPR32P1 is over-expressed in tumor.
HNSC are the cancer types where GPR32P1 tumor–normal differential expression is most reproducible.